NEW YORK – Abcam announced Wednesday it will acquire Eugene, Oregon-based life sciences research tools firm Marker Gene Technologies (MGT).
"MGT's team have expertise in the areas of biology, organic synthesis and fluorescence chemistry and are experienced in the creation of detection tools that enable enhanced understanding of biological processes," Abcam said in a statement, adding that the deal "brings additional proprietary assay development technologies and labeling capabilities to Abcam."